META Trial
Cross-source consensus on META Trial from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Where it comes from
Other
Other
Highlighted claims
- META is a multicentre randomised single-blind controlled trial in adults with ADHD and at least one addictive disorder. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
- The trial tests whether methylphenidate works better when paired with active cognitive remediation therapy targeting shared neuropsychological deficits. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
- The planned population includes 248 adults, split equally between active and control groups. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
- The trial emphasizes functional improvement rather than ADHD symptom reduction alone. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
- The trial is conducted across six French care centres, including university hospitals and public mental health centres. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol